Mingxiang Ye Selected Research

Mingxiang Ye Research Topics

Disease

14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 02/2015
14	Neoplasms (Cancer) 05/2024 - 02/2015
4	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2018
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2016
2	Pneumonia (Pneumonitis) 01/2024 - 12/2022
2	Adenocarcinoma of Lung 01/2018 - 01/2018
2	Breast Neoplasms (Breast Cancer) 02/2016 - 10/2015
1	Hypothyroidism 01/2024
1	Bites and Stings (Sting) 12/2022
1	Lymphoma (Lymphomas) 01/2022
1	COVID-19 10/2020
1	Acute Lung Injury 04/2017
1	Inflammation (Inflammations) 04/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2018
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
3	ErbB Receptors (EGF Receptor)IBA 01/2024 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2016
2	Programmed Cell Death 1 ReceptorIBA 12/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 11/2022 - 01/2022
2	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2016
2	CarcinogensIBA 07/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2015
1	Interferon Type IIBA 05/2024
1	LigandsIBA 01/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	InterferonsIBA 12/2022
1	entrectinibIBA 11/2022
1	tyrosine receptor (receptor, tyrosine)IBA 11/2022
1	larotrectinibIBA 11/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	Circular RNAIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	AntibodiesIBA 01/2021
1	Tight Junction ProteinsIBA 10/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2018
1	Cadherins (E-Cadherin)IBA 10/2018
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2018
1	bakuchiolIBA 04/2017
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 02/2016
1	Lapatinib (GW572016)FDA Link 02/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	Gefitinib (Iressa)FDA Link 01/2016
1	Docetaxel (Taxotere)FDA Link 10/2015
1	CurcuminIBA 02/2015

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2016
6	Immunotherapy 05/2024 - 01/2021
2	Drug Therapy (Chemotherapy) 07/2022 - 01/2022
1	Art Therapy 10/2020